The influence of hydroxyurea on oxidative stress in sickle cell anemia

Detalhes bibliográficos
Autor(a) principal: Torres,Lidiane de Souza
Data de Publicação: 2012
Outros Autores: Silva,Danilo Grünig Humberto da, Belini Junior,Edis, Almeida,Eduardo Alves de, Lobo,Clarisse Lopes de Castro, Cançado,Rodolfo Delfini, Ruiz,Milton Artur, Bonini-Domingos,Claudia Regina
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista brasileira de hematologia e hemoterapia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842012000600010
Resumo: OBJECTIVE: The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle cell anemia patients who did not take hydroxyurea was compared with a control group of 96 individuals without any hemoglobinopathy. METHODS: Oxidative stress was assessed by thiobarbituric acid reactive species production, the Trolox-equivalent antioxidant capacity and plasma glutathione levels. RESULTS: Thiobarbituric acid reactive species values were higher in patients without specific medication, followed by patients taking hydroxyurea and the Control Group (p < 0.0001). The antioxidant capacity was higher in patients taking hydroxyurea and lower in the Control Group (p = 0.0002 for Trolox-equivalent antioxidant capacity and p < 0.0292 for plasma glutathione). Thiobarbituric acid reactive species levels were correlated with higher hemoglobin S levels (r = 0.55; p = 0.0040) and lower hemoglobin F concentrations(r = -0.52; p = 0.0067). On the other hand, plasma glutathione levels were negatively correlated with hemoglobin S levels (r = -0.49; p = 0.0111) and positively associated with hemoglobin F values (r = 0.56; p = 0.0031). CONCLUSION: Sickle cell anemia patients have high oxidative stress and, conversely, increased antioxidant activity. The increase in hemoglobin F levels provided by hydroxyurea and its antioxidant action may explain the reduction in lipid peroxidation and increased antioxidant defenses in these individuals.
id ABHHTC-1_5c3c92bae39a48f4ff78f4e1a433dfca
oai_identifier_str oai:scielo:S1516-84842012000600010
network_acronym_str ABHHTC-1
network_name_str Revista brasileira de hematologia e hemoterapia (Online)
repository_id_str
spelling The influence of hydroxyurea on oxidative stress in sickle cell anemiaHemoglobinopathiesOxidative stressAnemia, sickle cellHydroxyureaOBJECTIVE: The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle cell anemia patients who did not take hydroxyurea was compared with a control group of 96 individuals without any hemoglobinopathy. METHODS: Oxidative stress was assessed by thiobarbituric acid reactive species production, the Trolox-equivalent antioxidant capacity and plasma glutathione levels. RESULTS: Thiobarbituric acid reactive species values were higher in patients without specific medication, followed by patients taking hydroxyurea and the Control Group (p < 0.0001). The antioxidant capacity was higher in patients taking hydroxyurea and lower in the Control Group (p = 0.0002 for Trolox-equivalent antioxidant capacity and p < 0.0292 for plasma glutathione). Thiobarbituric acid reactive species levels were correlated with higher hemoglobin S levels (r = 0.55; p = 0.0040) and lower hemoglobin F concentrations(r = -0.52; p = 0.0067). On the other hand, plasma glutathione levels were negatively correlated with hemoglobin S levels (r = -0.49; p = 0.0111) and positively associated with hemoglobin F values (r = 0.56; p = 0.0031). CONCLUSION: Sickle cell anemia patients have high oxidative stress and, conversely, increased antioxidant activity. The increase in hemoglobin F levels provided by hydroxyurea and its antioxidant action may explain the reduction in lipid peroxidation and increased antioxidant defenses in these individuals.Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular2012-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842012000600010Revista Brasileira de Hematologia e Hemoterapia v.34 n.6 2012reponame:Revista brasileira de hematologia e hemoterapia (Online)instname:Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)instacron:ABHHTC10.5581/1516-8484.20120106info:eu-repo/semantics/openAccessTorres,Lidiane de SouzaSilva,Danilo Grünig Humberto daBelini Junior,EdisAlmeida,Eduardo Alves deLobo,Clarisse Lopes de CastroCançado,Rodolfo DelfiniRuiz,Milton ArturBonini-Domingos,Claudia Reginaeng2013-01-21T00:00:00Zoai:scielo:S1516-84842012000600010Revistahttp://www.rbhh.org/pt/archivo/https://old.scielo.br/oai/scielo-oai.phpsbhh@terra.com.br||secretaria@rbhh.org1806-08701516-8484opendoar:2013-01-21T00:00Revista brasileira de hematologia e hemoterapia (Online) - Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)false
dc.title.none.fl_str_mv The influence of hydroxyurea on oxidative stress in sickle cell anemia
title The influence of hydroxyurea on oxidative stress in sickle cell anemia
spellingShingle The influence of hydroxyurea on oxidative stress in sickle cell anemia
Torres,Lidiane de Souza
Hemoglobinopathies
Oxidative stress
Anemia, sickle cell
Hydroxyurea
title_short The influence of hydroxyurea on oxidative stress in sickle cell anemia
title_full The influence of hydroxyurea on oxidative stress in sickle cell anemia
title_fullStr The influence of hydroxyurea on oxidative stress in sickle cell anemia
title_full_unstemmed The influence of hydroxyurea on oxidative stress in sickle cell anemia
title_sort The influence of hydroxyurea on oxidative stress in sickle cell anemia
author Torres,Lidiane de Souza
author_facet Torres,Lidiane de Souza
Silva,Danilo Grünig Humberto da
Belini Junior,Edis
Almeida,Eduardo Alves de
Lobo,Clarisse Lopes de Castro
Cançado,Rodolfo Delfini
Ruiz,Milton Artur
Bonini-Domingos,Claudia Regina
author_role author
author2 Silva,Danilo Grünig Humberto da
Belini Junior,Edis
Almeida,Eduardo Alves de
Lobo,Clarisse Lopes de Castro
Cançado,Rodolfo Delfini
Ruiz,Milton Artur
Bonini-Domingos,Claudia Regina
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Torres,Lidiane de Souza
Silva,Danilo Grünig Humberto da
Belini Junior,Edis
Almeida,Eduardo Alves de
Lobo,Clarisse Lopes de Castro
Cançado,Rodolfo Delfini
Ruiz,Milton Artur
Bonini-Domingos,Claudia Regina
dc.subject.por.fl_str_mv Hemoglobinopathies
Oxidative stress
Anemia, sickle cell
Hydroxyurea
topic Hemoglobinopathies
Oxidative stress
Anemia, sickle cell
Hydroxyurea
description OBJECTIVE: The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle cell anemia patients who did not take hydroxyurea was compared with a control group of 96 individuals without any hemoglobinopathy. METHODS: Oxidative stress was assessed by thiobarbituric acid reactive species production, the Trolox-equivalent antioxidant capacity and plasma glutathione levels. RESULTS: Thiobarbituric acid reactive species values were higher in patients without specific medication, followed by patients taking hydroxyurea and the Control Group (p < 0.0001). The antioxidant capacity was higher in patients taking hydroxyurea and lower in the Control Group (p = 0.0002 for Trolox-equivalent antioxidant capacity and p < 0.0292 for plasma glutathione). Thiobarbituric acid reactive species levels were correlated with higher hemoglobin S levels (r = 0.55; p = 0.0040) and lower hemoglobin F concentrations(r = -0.52; p = 0.0067). On the other hand, plasma glutathione levels were negatively correlated with hemoglobin S levels (r = -0.49; p = 0.0111) and positively associated with hemoglobin F values (r = 0.56; p = 0.0031). CONCLUSION: Sickle cell anemia patients have high oxidative stress and, conversely, increased antioxidant activity. The increase in hemoglobin F levels provided by hydroxyurea and its antioxidant action may explain the reduction in lipid peroxidation and increased antioxidant defenses in these individuals.
publishDate 2012
dc.date.none.fl_str_mv 2012-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842012000600010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842012000600010
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5581/1516-8484.20120106
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
publisher.none.fl_str_mv Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular
dc.source.none.fl_str_mv Revista Brasileira de Hematologia e Hemoterapia v.34 n.6 2012
reponame:Revista brasileira de hematologia e hemoterapia (Online)
instname:Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron:ABHHTC
instname_str Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
instacron_str ABHHTC
institution ABHHTC
reponame_str Revista brasileira de hematologia e hemoterapia (Online)
collection Revista brasileira de hematologia e hemoterapia (Online)
repository.name.fl_str_mv Revista brasileira de hematologia e hemoterapia (Online) - Associação Brasileira de Hematologia e Hemoterapia e Terapia Celular (ABHHTC)
repository.mail.fl_str_mv sbhh@terra.com.br||secretaria@rbhh.org
_version_ 1754213111639834624